T 2329/10 (Osteoclastogenesis bone disease osteoporosis/AMGEN) of 20.02.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T232910.20140220
- Date of decision
- 20 February 2014
- Case number
- T 2329/10
- Petition for review of
- -
- Application number
- 98918244.9
- IPC class
- A61K 38/17G01N 33/577C07K 16/28C12N 1/21A61K 31/70C07K 14/705C12N 15/12A61K 39/395G01N 33/68G01N 33/50C12N 5/10C12N 15/11
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- OSTEOPROTEGERIN BINDING PROTEINS AND RECEPTORS
- Applicant name
- Amgen Inc.,
- Opponent name
- Schering Corporation
Ablynx N.V. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Admissibility of Main Request (yes)
Amendments - extension beyond the content of the application as filed (no)
Sufficiency of disclosure - (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent based on the Main Request filed during the oral proceedings before the board, and a description to be adapted thereto.